Lanostane triterpenes from Ganoderma lucidum suppress the adipogenesis in 3T3-L1 cells through down-regulation of SREBP-1c

被引:36
作者
Lee, Iksoo [1 ]
Kim, JinPyo [1 ]
Ryoo, Inja [2 ]
Kim, YoungHee [2 ]
Choo, SooJin [2 ]
Yoo, IckDong [2 ]
Min, ByungSun [3 ]
Na, MinKyun [4 ]
Hattori, Masao [5 ]
Bae, KiHwan [1 ]
机构
[1] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea
[2] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea
[3] Catholic Univ Daegu, Coll Pharm, Gyeongbuk 712702, South Korea
[4] Yeungnam Univ, Coll Pharm, Gyeongbuk 712749, South Korea
[5] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan
关键词
Ganoderma lucidum; Lanostane triterpenes; Adipogenesis; SREBP-1c; FAS; ACC; INHIBITORY-ACTIVITY; ADIPOSE CONVERSION; HISTAMINE-RELEASE; OBESITY; ADIPOCYTE; DIFFERENTIATION; CONSTITUENTS; CULTURE;
D O I
10.1016/j.bmcl.2010.06.093
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several lanostane triterpenes [butyl ganoderate A (1), butyl ganoderate B (2), butyl lucidenate N (3), and butyl lucidenate A (4)] bearing a butyl ester side chain from the fruiting bodies of Ganoderma lucidum exhibited considerable inhibitory effects on adipogenesis in 3T3-L1 cells. The inhibitory mechanism of 1 and 3 on adipogenesis in 3T3-L1 cells was investigated; we found that the mRNA and protein expression levels of SREBP-1c were reduced by treatment with 1 and 3 versus the untreated control. Further-more, compounds 1 and 3 suppressed the mRNA expression levels of FAS and ACC. These results demonstrate that inhibition of adipogenesis in 3T3-L1 cells by treatment with 1 and 3 may be mediated in part through down-regulation of the adipogenic transcription factor SREBP-1c and its target genes, such as FAS and ACC. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5577 / 5581
页数:5
相关论文
共 25 条
  • [1] REGULATION OF ADIPOCYTE DEVELOPMENT
    CORNELIUS, P
    MACDOUGALD, OA
    LANE, MD
    [J]. ANNUAL REVIEW OF NUTRITION, 1994, 14 : 99 - 129
  • [2] In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes
    El Hadri, K
    Glorian, M
    Monsempes, C
    Dieudonné, MN
    Pecquery, R
    Giudicelli, Y
    Andreani, M
    Dugail, I
    Fève, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) : 15130 - 15141
  • [3] SPONTANEOUS HERITABLE CHANGES LEADING TO INCREASED ADIPOSE CONVERSION IN 3T3-CELLS
    GREEN, H
    KEHINDE, O
    [J]. CELL, 1976, 7 (01) : 105 - 113
  • [4] ESTABLISHED PRE-ADIPOSE CELL LINE AND ITS DIFFERENTIATION IN CULTURE .2. FACTORS AFFECTING ADIPOSE CONVERSION
    GREEN, H
    KEHINDE, O
    [J]. CELL, 1975, 5 (01) : 19 - 27
  • [5] Hobbs C., 1995, MED MUSHROOMS EXPLOR
  • [6] SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
    Horton, JD
    Goldstein, JL
    Brown, MS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (09) : 1125 - 1131
  • [7] MEDICINAL BENEFITS OF THE MUSHROOM GANODERMA
    JONG, SC
    BIRMINGHAM, JM
    [J]. ADVANCES IN APPLIED MICROBIOLOGY, 1992, 37 : 101 - 134
  • [8] Kim DH, 1999, BIOL PHARM BULL, V22, P162, DOI 10.1248/bpb.22.162
  • [9] KIMURA S, 1988, NUTR SCI VITAM, V34, P433
  • [10] KOHDA H, 1985, CHEM PHARM BULL, V33, P1367